HC Wainwright & Co. analyst Joseph Hafling maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $60 to $73.
Google’s Study Claims Russia Resorting To Cyberattacks Against Ukraine
Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Google researchers found growing evidence of pro-Russian hackers and online activists working with the country's military intelligence agency.
